Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease
-
Taoping Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
-
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
-
Quest Analytics Announces Strategic Integration Partnership with Arcadia
-
Treetoscope and Nutrien Team Up to Transform Irrigation Efficiency Across the Americas
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2025
-
CHERYL HINES' TRAILER PROWLING TO SARDINIA
-
Graphite One Enters FAST-41 60-Day Planning and Timetable Period
-
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
-
Toyota Prius Plug-in Hybrid Gets Edgier with New Nightshade Edition
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
THCA Flower 2025: NexZen Extracts Unveils 2025 THCA Flower Lineup Featuring Godfather OG, Sex Panther, and Gelato
-
Delta 8 Gummies 2025: NexZen Extracts Sets the Standard for Flavor, Potency, and Quality
-
Blue Sky Uranium Commences Drill Program to Accelerate Advancement of the Ivana Uranium-Vanadium Project, Argentina
-
Roundhill Announces Distribution Calendar Changes: ETF Lineup to Offer Distributions Every Weekday
-
Lumion Closes $10.7M to Power the Ultimate Operating System for Trade Schools, Tackling the Skilled Labor Gap
-
RTX's Pratt & Whitney to provide affordable mass propulsion for Leidos' Small Cruise Missile program
-
Axio BioPharma Expands Advisory Board with Leaders in Biologics Development and Manufacturing
-
KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT
-
Satellos Bioscience to Participate in PPMD’s Annual Conference in Las Vegas
-
Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream
-
Watch a New Episode of Advancements on Saturday, June 21st at 8:00 pm ET
-
Dr. Jethro Ekuta Joins BP Logix Life Sciences Strategic Advisory Board
-
CleanCapital Expands Distributed Generation Credit Facility with Rabobank, Leveraging Energetic Capital’s EneRate Credit Cover®
-
Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer
-
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI
-
Lazard Releases 2025 Levelized Cost of Energy+ Report
-
Constellation‘s Deal With Calpine Approved by New York Public Service Commission
-
KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Pat
-
The T1D Fund Announces Lucio Iannone, Ph.D., as Managing Director to Accelerate Investments in Curative T1D Therapies
-
Enable Launches the Tariff Price Planner, Helping Businesses Respond Instantly to Tariff Volatility
-
American Express Announces Major Updates Coming to U.S. Consumer and Business Platinum Cards® Later This Year
-
Pebblebrook Hotel Trust Declares Dividends for Second Quarter 2025
-
Further Updated Briefing and Discovery Schedule for Citgo Sale Hearing
-
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
-
JD Lands on Las Vegas Strip in Key Moment for US Growth Strategy
-
iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment
-
Portillo’s Adds Veteran Restaurant Leader Gene Lee to Board of Directors
-
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
-
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
-
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
-
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
-
Coda Octopus Group Reports Fiscal Second Quarter 2025 Financial Results
-
Mavenir Signs Debt Recapitalization Transaction to Drive Continued Growth
-
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
-
Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
-
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
-
Nokia announces changes to Group Leadership Team
-
Signify share repurchase period update

